![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Follow-up of SVR Durability and Viral Resistance in Patients with Chronic Hepatitis C Treated with Telaprevir-Based Regimens:
Interim Analysis from the EXTEND Study
|
|
|
Reported by Jules Levin AASLD Nov 5-9 2011 SF
Kenneth E. Sherman, Mark S. Sulkowski, Fabien Zoulim, Alfredo Alberti, Lee-Jen Wei, James C. Sullivan, Emily C. Martin, Tara L. Kieffer, Sandra De Meyer, Gaston Picchio, Camilla S. Graham, and Stefan Zeuzem
on behalf of the EXTEND Study Team
![AASLD1.gif](../images/110911/110911-1/AASLD1.gif)
![AASLD2.gif](../images/110911/110911-1/AASLD2.gif)
![AASLD3.gif](../images/110911/110911-1/AASLD3.gif)
![AASLD4.gif](../images/110911/110911-1/AASLD4.gif)
![AASLD5.gif](../images/110911/110911-1/AASLD5.gif)
![AASLD6.gif](../images/110911/110911-1/AASLD6.gif)
![AASLD7.gif](../images/110911/110911-1/AASLD7.gif)
![AASLD8.gif](../images/110911/110911-1/AASLD8.gif)
![AASLD9.gif](../images/110911/110911-1/AASLD9.gif)
![AASLD10.gif](../images/110911/110911-1/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|